Selected article for: "autoimmune disease and inflammatory disease"
Author: Saravi, Babak; Li, Zhen; Lang, Corinna N.; Schmid, Bonaventura; Lang, Frauke K.; Grad, Sibylle; Alini, Mauro; Richards, Robert Geoffrey; Schmal, Hagen; Südkamp, Norbert; Lang, Gernot M.
Title: The Tissue Renin-Angiotensin System and Its Role in the Pathogenesis of Major Human Diseases: Quo Vadis?
  • Cord-id: 2d4u1s4e
  • Document date: 2021_3_15
    • ID: 2d4u1s4e
    Snippet: Evidence has arisen in recent years suggesting that a tissue renin-angiotensin system (tRAS) is involved in the progression of various human diseases. This system contains two regulatory pathways: a pathological pro-inflammatory pathway containing the Angiotensin Converting Enzyme (ACE)/Angiotensin II (AngII)/Angiotensin II receptor type 1 (AGTR1) axis and a protective anti-inflammatory pathway involving the Angiotensin II receptor type 2 (AGTR2)/ACE2/Ang1–7/MasReceptor axis. Numerous studies
    Document: Evidence has arisen in recent years suggesting that a tissue renin-angiotensin system (tRAS) is involved in the progression of various human diseases. This system contains two regulatory pathways: a pathological pro-inflammatory pathway containing the Angiotensin Converting Enzyme (ACE)/Angiotensin II (AngII)/Angiotensin II receptor type 1 (AGTR1) axis and a protective anti-inflammatory pathway involving the Angiotensin II receptor type 2 (AGTR2)/ACE2/Ang1–7/MasReceptor axis. Numerous studies reported the positive effects of pathologic tRAS pathway inhibition and protective tRAS pathway stimulation on the treatment of cardiovascular, inflammatory, and autoimmune disease and the progression of neuropathic pain. Cell senescence and aging are known to be related to RAS pathways. Further, this system directly interacts with SARS-CoV 2 and seems to be an important target of interest in the COVID-19 pandemic. This review focuses on the involvement of tRAS in the progression of the mentioned diseases from an interdisciplinary clinical perspective and highlights therapeutic strategies that might be of major clinical importance in the future.

    Search related documents:
    Co phrase search for related documents
    • ace angiotensin ii and acei arb therapy: 1, 2
    • ace angiotensin ii and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • ace angiotensin ii and acute lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • ace angiotensin ii and acute lung injury attenuate: 1
    • ace angiotensin ii and acute respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • ace inhibition and acute ards respiratory distress syndrome: 1
    • ace inhibition and acute lung injury: 1, 2, 3
    • ace inhibition and acute respiratory distress syndrome: 1
    • ace inhibitor and acei arb therapy: 1
    • ace inhibitor and acute ards respiratory distress syndrome: 1, 2, 3, 4
    • ace inhibitor and acute lung injury: 1, 2, 3, 4
    • ace inhibitor and acute respiratory distress syndrome: 1, 2, 3, 4, 5
    • ace inhibitor arb acei and acei arb therapy: 1
    • ace inhibitor arb acei and acute lung injury: 1
    • ace inhibitor arb and acei arb therapy: 1
    • ace inhibitor arb and acute ards respiratory distress syndrome: 1, 2, 3
    • ace inhibitor arb and acute lung injury: 1, 2
    • ace inhibitor arb and acute respiratory distress syndrome: 1, 2, 3, 4
    • ace inhibitor arbs and acute lung injury: 1